Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Summaries for patients. Using a type of blood pressure medicine, angiotensin-converting enzyme inhibitors, to prevent worsening of kidney disease unrelated to diabetes.

    ACE Inhibition in Progressive Renal Disease Study Group.

    Ann Intern Med. 2001 Jul 17;135(2):S-21. No abstract available. PMID: 11463005 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

    Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

    Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299. PMID: 11453706 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

    Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

    Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Blood pressure and urine protein levels with the least risk for worsening kidney disease.

    [No authors listed]

    Ann Intern Med. 2003 Aug 19;139(4):I36. No abstract available. PMID: 12965997 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?

    Bakris GL.

    J Clin Hypertens (Greenwich). 2007 Jun;9(6):413-5. No abstract available. PMID: 17541325 [PubMed - indexed for MEDLINE]Related articles

    8.

    Introduction: nature of microalbuminuria, proteinuria, and progressive renal disease.

    Mogensen CE.

    J Diabetes Complications. 1995 Jan-Mar;9(1):2-6. Review. No abstract available. PMID: 7734738 [PubMed - indexed for MEDLINE]Related articles

    9.

    [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]

    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

    Presse Med. 2002 Nov 9;31(36):1714-20. Review. French. PMID: 12467154 [PubMed - indexed for MEDLINE]Related articles

    10.

    Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

    Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease.

    Kidney Int. 2001 Sep;60(3):1131-40.PMID: 11532109 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels?

    Mulrow CD, Townsend RR.

    Ann Intern Med. 2003 Aug 19;139(4):296-8. No abstract available. PMID: 12965986 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Slowing nephropathy progression: focus on proteinuria reduction.

    Bakris GL.

    Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1:S3-10. Review.PMID: 18178794 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Update on calcium antagonists and the kidney.

    Tobe S.

    Curr Opin Nephrol Hypertens. 2003 May;12(3):309-15. Review.PMID: 12698071 [PubMed - indexed for MEDLINE]Related articles

    14.

    Angiotensin converting enzyme inhibitors in nondiabetic renal disease.

    Maschio G, Marcantoni C.

    Curr Opin Nephrol Hypertens. 1998 May;7(3):253-7. Review.PMID: 9617554 [PubMed - indexed for MEDLINE]Related articles

    15.

    Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease.

    [No authors listed]

    Ann Intern Med. 2005 Mar 1;142(5):I42. No abstract available. PMID: 15738448 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

    Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

    17.

    Renal protection in hypertensive patients: selection of antihypertensive therapy.

    Wenzel RR.

    Drugs. 2005;65 Suppl 2:29-39. Review.PMID: 16398060 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hypertension and progression of renal disease.

    Maschio G, Oldrizzi L, Marcantoni C, Rugiu C.

    J Nephrol. 2000 May-Jun;13(3):225-7. Review.PMID: 10928300 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.

    Shand BI, Lewis JG, Elder PA, Agarwal M.

    Clin Nephrol. 2002 Oct;58(4):321-4. No abstract available. PMID: 12400851 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

    Bianchi S, Bigazzi R, Campese VM.

    Am J Kidney Dis. 2005 Jul;46(1):45-51.PMID: 15983956 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data